搜索临床试验以:2mg格列美脲/20mg阿托伐他汀FDC
总计1436个结果
-
Novartis Pharmaceuticals终止特应性皮炎美国, 英国, 德国, 匈牙利, 俄罗斯联邦, 台湾, 比利时, 荷兰, 日本, 奥地利, 芬兰, 斯洛伐克, 捷克语, 加拿大, 冰岛, 波兰
-
Reade Rheumatology Research InstituteZonMw: The Netherlands Organisation for Health Research and Development; Sint Maartenskliniek完全的
-
Insel Gruppe AG, University Hospital BernUniversity of Bern尚未招聘
-
Ultragenyx Pharmaceutical IncNovartis; Mereo BioPharma完全的
-
Daping Hospital and the Research Institute of Surgery...AstraZeneca未知
-
Acura Pharmaceuticals Inc.King Pharmaceuticals is now a wholly owned subsidiary of Pfizer完全的
-
The University of Texas Health Science Center,...Cures Within Reach完全的
-
Menarini International Operations Luxembourg SA完全的
-
Seoul National University HospitalMinistry of Food and Drug Safety, Korea完全的
-
Merck Sharp & Dohme LLC完全的
-
Hospital Universitari Vall d'Hebron Research Institute未知
-
University of California, San Diego主动,不招人
-
Lipella Pharmaceuticals, Inc.William Beaumont Hospitals完全的
-
Boryung Pharmaceutical Co., LtdPusan National University Hospital; Ulsan University Hospital; Daegu Catholic University Medical... 和其他合作者完全的
-
Peking University Cancer Hospital & Institute未知
-
Khon Kaen UniversityThai Rheumatism Association完全的胃食管反流 | 系统性硬化症 | 质子抑制剂
-
Tel-Aviv Sourasky Medical CenterTel Aviv Medical Center完全的